Resin specialist Purolite on scaling up, sustainability and its BIO Boston plans
BPR: What are Purolite’s plans for BIO International in Boston?
At BIO, Purolite will showcase its flagship Praesto Jetted A50 HipH resin technology. The team will also be on hand to discuss how Purolite can help improve bioprocessing processes.
In addition, Purolite’s global Field Applications Services team will be available to discuss downstream bioprocessing challenges and solutions, alongside joint exhibitors, Ecolab Life Sciences and Bioquell, at booth 1873.
Aaron Moulin, field applications specialist, will also give a technical talk on the benefits of HipH resin technology at the BIO theatre.
BPR: What are you working on right now?
The Purolite team is continuing to innovate and scale up to meet industry demands with its Praesto Jetted A50 HipH resin innovation. This novel Protein A resin is specifically designed for elution of Fc-containing molecules at higher pH levels to help increase downstream productivity.
In addition, the company recently extended its strategic partnership with Repligen for five new high-performance ligands to meet the evolving bioprocessing market needs.
Purolite has also invested in sustainability within its business and manufacturing processes.
For example, the company’s Praesto chromatography resins are manufactured using its patented Jetting technology, which is faster, more environmentally friendly, and produces consistent beads with uniform particle size distribution.
This results in shorter lead times and faster mAb processing while contributing to customers’ sustainability goals, as the process consumes significantly lower volumes of water, fewer solvents and generates less CO2 compared with traditional batch emulsification manufacturing methods.
BPR: Tell us about the company’s growth and expansion plans…
As a resin specialist, Purolite is ready to respond to new customer demands. The manufacturer is constantly developing its resin products to provide new solutions to tackle a diverse array of pharmaceutical manufacturing challenges.
The company is currently expanding its manufacturing capacity to address increasing global demand for protein A resins. Its future agarose manufacturing facilities will be equipped with Purolite’s advanced Jetting technology, leveraging a smaller manufacturing footprint and quicker deployment.
BPR: How do you invest in people?
Purolite’s investment in talent is one of the key components of its growth and progress. The company is actively recruiting in a range of skilled areas across its global sites to ensure that it continues to deliver above and beyond customer expectations.
It is Purolite’s relationships and personal approach that customers value and its people are key to delivering that experience.